Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Dekkun
Growth Score
68
CB Rank
1331595
Heat Score
24
Save
Actions
Dekkun develops a humanized monoclonal antibody, DKN-01, for the treatment of cancer and for strengthening cancer-associated bone lesions.
Founded
obfuscated
obfuscation
Private
Venture - Series Unknown
Cambridge
,
Massachusetts
,
United States
11-50
Biotechnology
Health Care
Dekkun
Section: Overview
Actions